Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
48.2M
-
Shares change
-
+723K
-
Total reported value, excl. options
-
$197M
-
Value change
-
-$2.13M
-
Put/Call ratio
-
0.36
-
Number of buys
-
53
-
Number of sells
-
-51
-
Price
-
$4.10
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2018
152 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q4 2018.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.2M shares
of 159M outstanding shares and own 30.32% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (8.2M shares), venBio Select Advisor LLC (4.75M shares), BlackRock Inc. (4.52M shares), STATE STREET CORP (4.34M shares), BRIDGER MANAGEMENT, LLC (3.79M shares), GREAT POINT PARTNERS LLC (3M shares), FMR LLC (2.72M shares), Vanguard Group Inc (1.98M shares), CREDIT AGRICOLE S A (1.31M shares), and RENAISSANCE TECHNOLOGIES LLC (876K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.